Roto-Gro International Limited Overview
Roto-Gro International was a sub-scale Australian-listed, Canadian-operated agricultural technology company. Its core asset was a patented stackable, rotatable hydroponic "Rotational Garden System". In this design, plants grow on the inside of a slowly revolving cylinder around a central light source, which multiplies canopy area per square metre of floor space. The company aimed to commercialise the technology for two markets: licensed (lawful) cannabis cultivation and indoor vertical farming of perishable foods. It sold three things around the hardware: fertigation (automated nutrient delivery), iGrow control software, and growing-management services. Between its A$3.6M IPO in February 2017 and 2022, it never achieved more than A$1.14M of annual sales. It accumulated A$37.3M of losses and relied entirely on equity and convertible-note funding. The Canadian operating subsidiaries entered bankruptcy on 31 May 2022, and the listed parent lost control of every operating asset. Today it is a delisted, asset-less shell (net liabilities A$13,128 at 30 June 2022) facing deregistration.
Company's own description (latest annual report)
The FY2022 Annual Report (lodged 31 August 2023) describes the principal activity, until 31 May 2022, as the production and sale of patented and proprietary Rotational Garden Systems (the "RotoGro Garden Systems"). It also covered the sale and production of advanced automated nutrient delivery and water management systems (the "Fertigation Systems"). The report states that the company lost effective control of its subsidiaries when a bankruptcy trustee was appointed to the Canadian operating subsidiaries. The principal activity therefore ceased on 31 May 2022. In the segment note, the group described itself as operating across the agricultural industry, providing technology and cultivation solutions for advanced indoor hydroponic growing applications.
Independent characterisation
RotoGro was, in substance, a pre-commercial hardware-plus-IP venture. Commercial traction never matched its announced pipeline. Its business model evolved through three phases.
-
Equipment vendor (FY2017–FY2019). It sold rotary garden units into licensed cannabis facilities in Canada, such as the A$2.3M purchase order announced 4 April 2018. In 2018 it acquired Nevada-based Hanson Fertigation to add a water-treatment and nutrient-management business line. Sales peaked at A$1.14M in FY2019 (FY2021 Annual Report, five-year summary).
-
Attempted vertical integration (FY2019–FY2020). It tried to become a cannabis cultivator and processor in its own right through two deals. One was the CAD 11M agreement to acquire Supra THC Services Inc. (and its Health Canada Dealer's Licence) from Valens GroWorks, announced 29 October 2018. The other was a perishable-foods venture with Gibio Inc. Both were unwound or written off. The Gibio investment was written off in FY2020 (A$439,897). The US fertigation subsidiary was placed into voluntary administration and dissolved on 23 June 2020.
-
Asset-light licensing (FY2021–FY2022). Management described the strategy as "less capital-intensive business partnerships and collaborations" (Verity Greens announcement, December 2020). This rested on three agreements:
-
an A$10M Technology Licence Agreement with Verity Greens Inc., covering technology sales, annual software licence fees, manufacturing fees, and a 20-year net profit share;
-
a CAD 1.903M purchase-and-sale agreement with Canniberia LDA (Portugal);
-
a Growing Management Services Agreement with Canniberia LDA, providing for a 25% share of EBITDA from cannabis sales. None of these produced recognised revenue before the operating subsidiaries failed. FY2021 sales were nil and FY2022 sales were A$27,117.
-
Revenue model mix
| Revenue stream | Description | Evidence of realisation |
|---|---|---|
| Product sales (hardware) | RotoGro Garden Systems (Model 420, Model 710), fertigation / nutrient management systems | FY2018 A$464k; FY2019 A$1.14M; FY2020 A$679k (unit sales) plus A$226k fertigation (discontinued); FY2021 nil; FY2022 A$27k |
| Software licensing | iGrow Enterprise Edition; "RotoGro Facility Edition"; annual licence fees under the Verity Greens TLA | No software revenue separately disclosed |
| Manufacturing / technology licensing | Manufacturing and technology-use licences (Verity Greens) | No revenue recognised |
| Services / profit share | Growing management services (Canniberia: 25% of EBITDA); design and fit-out services | No revenue recognised |
| Government grants (other income) | COVID-19 subsidies, mainly the Canada Emergency Wage Subsidy | FY2020 A$170k; FY2021 A$519k; FY2022 A$104k |
Value-chain position, customers and end-markets
Value-chain position: Upstream cultivation-infrastructure supplier (capital equipment, controls, IP) to growers. In 2018–2019 it attempted to move downstream into cultivation and processing.
Customer types: - Licensed cannabis producers in Canada, such as Wolf Island Cannabis Inc. (Ontario);
-
prospective licensed producers in Europe, such as Canniberia LDA (Portugal);
-
indoor vertical-farm operators, such as Verity Greens Inc. (Canada);
-
fresh-produce growers, such as Fresh Leaf (herb trials in Canada and Australia, under an MOU);
-
in the Hanson era, Nevada cannabis facilities, viticulture and perishable-food growers.
End-markets: Lawful (medical and adult-use) cannabis, with Canada as the core market after legalisation on 17 October 2018. Controlled-environment agriculture / indoor vertical farming of leafy greens, herbs and fruiting crops. Space agriculture as a demonstration niche (NASA/CSA Deep Space Food Challenge, August 2021).
Strategy
Stated strategy (themes from FY2021 Annual Report and investor materials — the last period of active strategy)
-
Pioneer of rotational garden systems in indoor vertical farming. Defend and expand the patent portfolio (Australian patent grant; RavenQuest settlement; three US provisional filings).
-
Asset-light commercialisation. Pursue "less capital-intensive business partnerships and collaborations" through technology licences, recurring software fees and profit shares rather than owning cultivation facilities (Verity Greens TLA, December 2020).
-
Dual end-market focus. Target lawful cannabis (Model 420; Canniberia; Wolf Island) and perishable foods (Model 710; Verity Greens; Fresh Leaf), with a sales pipeline across the USA, Europe and Australia.
-
Full-facility automation. Combine Facility Edition software, AGVs, LED lighting and direct-injection feed to cut labour, power and water costs.
-
Capital-markets access. Plan a CSE dual listing for North American valuation comparables and capital access (2021).
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
None. The company has had no operations since 31 May 2022 and no ASX listing since 1 March 2024. Its last known periodic report was the 31 January 2024 quarterly (Appendix 4C). The only corporate event in the window is the ASIC strike-off action initiated 6 August 2026 (delisted.com.au). No restructuring proposal, recapitalisation, reverse takeover, or deed of company arrangement has been disclosed.
Last disclosed recovery strategy (FY2022 Annual Report, going-concern note)
The directors stated that continuing as a going concern depended on three things:
-
raising equity from capital markets;
-
curtailing corporate overheads;
-
acquiring additional assets and attracting capital "to secure the future of the Company" (a shell-reuse / recapitalisation strategy).
No such transaction was announced before delisting.
Guidance and medium-term targets
Not publicly disclosed. The FY2021 report omitted likely developments to avoid "unreasonable prejudice". The company never issued financial guidance. The only quantitative targets were the CEO performance hurdles in the 2019 Clode agreement, none of which were met:
-
A$5M cumulative contracted sales by 31 Dec 2020;
-
A$10M by 31 Dec 2021;
-
A$20M by 31 Dec 2022;
-
a first joint-venture order of at least 100 eight-foot rotational gardens by 31 Dec 2020.
ESG and sustainability commitments
None formally stated. The implicit sustainability thesis was lower water and power use per kilogram of produce versus other indoor farming systems (FY2021 Annual Report R&D section). No quantified targets were set.
Products & Services
Because the group never reported product segments, the catalogue is organised by product family. Pricing was not publicly disclosed except where noted.
Product Portfolio
| # | Product / offering | Description & key capabilities | Target customer | Launch / latest version | Pricing (if disclosed) |
|---|---|---|---|---|---|
| 1 | RotoGro Rotational Garden System (core patented platform) | Stackable, modular, rotatable hydroponic garden. Plant trays mount on rotating rails around a central light, so canopy area per floor square metre is multiplied. Protected by Canadian Patent 2,908,184 (20-year term from filing; ownership confirmed in the FY2021 RavenQuest settlement) and Australian Patent 2015243012 | Licensed cannabis producers; vertical farms | Platform from 2015; patents granted by FY2021 | n/d per unit. Fresh Leaf MOU implies ~A$25,000 for one unit (FY2021 Annual Report) |
| 2 | Model 420 / "RotoGro 420 IT System" | Cannabis-optimised rotational garden. Company trials reported 7–9 lb per system every 60 days with consistent THC/CBD (Nov 2018 operational update) | Licensed cannabis cultivators | Commercial from ~2017–2018; LED control features added FY2021 | — |
| 3 | Model 710 Garden System | Perishable-foods variant (leafy greens, herbs; trials of strawberries, bok choy, peppers, tomatoes, snacking cucumbers). Integrates proprietary LED lighting and a direct-injection feed system; management claimed lower power and water use and higher yield per m² (FY2021 Annual Report). Basis of the Verity Greens order (624 units, potentially 1,872) | Indoor vertical farms; produce growers | Featured from Dec 2020; six-stacked automation test units FY2021 | n/d. Verity TLA headline value A$10M |
| 4 | Supporting automation technology | RotoGro-designed elevator systems, motorised actuators and tray handling (Dec 2020 investor material) | Large-scale vertical farms | FY2021 | — |
| 5 | Automated Guided Vehicles (AGVs) | In-house AGVs for automated tray insertion and removal on stacked Model 710s; development with international automation engineering firms | Full-facility automation buyers | Testing FY2021; not commercialised | — |
| 6 | Fertigation Systems / Plant Nutrient Management System | Automated nutrient delivery and water management. Originated with Hanson Fertigation's "patent-pending fully-automated nutrient delivery system" (2018). Integrated with iGrow to automate whole feeding schedules (FY2021) | Cannabis, greenhouse, field, viticulture growers | Acquired 2018; US business dissolved June 2020; integrated system retained in Canada | n/d. Fertigation sales A$225.5k in FY2020 |
| 7 | Water treatment services (Hanson legacy) | Water treatment and fertigation design, installation and service. Hanson had served more than 12 licensed cannabis facilities in Nevada | Nevada growers | 2018–2020 | — |
| 8 | iGrow® Enterprise Edition software | Automation, monitoring and configuration of the cultivation process. FY2021 redesign added a new interface, security layers, email alerts, and LED control for Models 710 and 420 | System owners | Redesigned FY2021 | Annual licence fees contemplated under the Verity TLA; amount n/d |
| 9 | RotoGro Facility Edition software | Facility-scale control layer for Model 710 automation, AGVs and tray handling | Vertical farm operators | Under commercialisation FY2021 | — |
| 10 | Proprietary LED lighting solution | LED system designed for the rotational geometry | Model 710/420 users | FY2021 trials | — |
| 11 | Direct-injection feed system / plant tray feed system | Feed nozzle and plant tray feed system (US provisional 63/088,597, also reported as 63/088,598) | System users | Filed FY2021 | — |
| 12 | Growing Management Services | Dedicated cultivation management in exchange for a profit share (Canniberia: 25% of EBITDA from cannabis flower sales) | Licence holders lacking cultivation know-how | Agreement FY2021; conditional on licence | Profit share |
| 13 | Technology & manufacturing licences | Rights to use and manufacture RotoGro technology in a field of use (Verity Greens: perishable foods; 20-year initial term with net profit share) | Licensees | Dec 2020 | A$10M headline; components n/d |
| 14 | Design & fit-out services | Facility design and fit-out solutions for cannabis and perishable-food facilities | New facilities | 2018 onward | — |
| 15 | Proprietary genetics – "Black Romulan" cannabis strain | Strain developed for the 420 IT System. Compact buds and mild aroma; THC reported above 20% in initial tests (Dec-2020 quarter) | Cannabis cultivators | Dec 2020 quarter | Not commercialised |
| 16 | Space-agriculture application | Adaptation for the NASA/CSA Deep Space Food Challenge (Phase 1) | Space agencies (demonstration) | Aug 2021 | — |
Financial Narrative
The analysis uses the five most recent audited years (FY2018–FY2022). FY2022 accounts carry an audit disclaimer of opinion and consolidate subsidiaries only to 31 December 2021. FY2023 accounts were not located.
Income statement
Blank cells = not publicly disclosed in reviewed sources: Sources: FY2021 Annual Report (five-year summary FY2017–FY2021; FY2020–FY2021 income statements); FY2022 Annual Report (five-year summary FY2018–FY2022; FY2022 income statement).
FY2020 EPS: −11.20c is the continuing-operations figure used in the five-year table; total EPS including discontinued operations was −11.39c.
Discrepancy: the FY2020 five-year table gives EBITDA of −A$14.28M, while the FY2021 segment note gives −A$14.72M for FY2020 (including discontinued operations). Both are shown in the respective filings.
FY2022 EBITDA (−A$12.29M) includes the A$8.41M impairment and A$1.36M deconsolidation expense.
Margins and growth
Revenue CAGR, FY2018–FY2022: approximately −50.8% per year (A$464k → A$27k). FY2017 sales were A$3,276, so the FY2017–FY2019 build-up was rapid from a negligible base, but it reversed after FY2019. Margins are not meaningful in FY2021 because there was no revenue.
Commentary.
The income statement shows a company that never escaped the commercialisation valley. Revenue peaked in FY2019 at A$1.14M. That year combined the Canadian equipment orders (including the A$2.3M order announced in April 2018, recognised in part) with first-year Hanson fertigation revenue.
FY2020 shows the first inflection. Sales fell 40% and the company sold units below cost (gross loss A$358k on A$679k of sales, implying −52.8% gross margin). It also impaired A$9.66M of intangibles and wrote off the Gibio investment.
FY2021 was the "licensing pivot" year, with zero sales. The loss narrowed to A$4.61M only because there were no impairments. A$0.90M of the cost base was share-based payments and A$0.50M was convertible-note finance costs.
FY2022 crystallised the collapse. An A$8.01M impairment of the cash-generating unit at 31 December 2021, plus A$0.40M at 30 June 2022 and A$1.36M of deconsolidation expense, wiped out all remaining non-current assets.
Cumulative losses reported over FY2017–FY2022 total ≈A$43.5M. Accumulated losses on the balance sheet were A$37.26M at 30 June 2022, after A$6.9M of option and right lapse transfers.
Balance sheet
FY2019 closing equity was A$22,034k and closing cash A$3,009k (FY2021 Annual Report statement of changes in equity and cash flow). Other FY2018–FY2019 balance-sheet lines were not publicly disclosed in reviewed sources. Net debt excluding leases was −A$345.5k (FY2020), −A$1,638.4k (FY2021) and −A$116.2k (FY2022). MarketScreener reports net debt of −A$1.44M (FY2021) and −A$116k (FY2022), consistent with the lease-inclusive figures.
Commentary.
No borrowings: The group never carried bank debt; the only financing liabilities were property and vehicle leases in Canada.
Asset base was almost entirely capitalised IP: Intangibles were 76% of total assets in FY2020 and 66% in FY2021, so asset value depended on the IP being commercialised.
Contract liabilities: These are customer deposits (A$524.6k at FY2021, rising to A$751.1k before deconsolidation, including the Wolf Island deposit). They were extinguished on deconsolidation, which implies customers who prepaid were left as creditors of the bankrupt Canadian subsidiary.
Year-end FY2022: The parent held A$116k of cash against A$169k of payables, giving negative net assets of A$13,128.
Cash flow
Commentary.
-
Over FY2020–FY2022 the business burned ≈A$9.96M of free cash flow and funded it almost entirely from new equity (A$7.45M) and a convertible note (A$1.25M).
-
The FY2022 cash statement is notable: A$1.197M of cash, raised largely in the July 2021 A$2.2M placement, sat in the Canadian subsidiaries. It was derecognised on loss of control, so shareholders who funded the July 2021 placement effectively saw those funds absorbed into the bankruptcy.
Ratios
Not meaningful or not computable:
-
ROIC: negative NOPAT and an IP-dominated capital base.
-
Net debt / EBITDA: net cash and negative EBITDA.
-
Cash conversion cycle: no receivables or revenue base in FY2021; COGS-based inventory days are distorted.
Ratio definitions: ROE uses average equity. ROA uses average total assets (FY2019 total assets n/d). The FY2022 ROE of −241.7% matches the aggregator Wisesheets (−241.74%).
Trend synthesis.
-
The only "improvement" was the FY2021 current ratio, driven by equity raises.
-
The defining inflections were the FY2020 impairment, which recognised that the cannabis-equipment thesis was not delivering, and the FY2022 bankruptcy and deconsolidation, which ended the business.
-
Drivers throughout were:
-
sub-scale sales against a fixed Canadian R&D and manufacturing base;
-
heavy reliance on equity compensation (share-based payments of A$708k, A$900k and A$302k in FY2020–FY2022);
-
failure to convert headline agreements (Verity A$10M; Canniberia A$2.03M) into delivered orders.
-
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Jurisdiction | Function | Status |
|---|---|---|---|
Roto-Gro International Limited | Australia | Listed parent / holding | Delisted 1 Mar 2024; strike-off initiated Aug 2026 |
Roto-Gro World Wide (Canada) Inc. | Canada | Principal operating company (manufacturing, R&D, sales) | Bankrupt 31 May 2022; deconsolidated |
Roto-Gro World Wide Inc. | Mauritius → British Virgin Islands (15 Oct 2021) | Holder of group intangible assets | Deconsolidated (no records available to directors) |
Roto-Gro Inc. | Canada | Original patent-owning company (Australian Patent 2015243012) | Deconsolidated |
Roto-Gro International Inc. | Canada | Subsidiary | Deconsolidated |
Roto-Gro Intellectual Property Inc. (Roto-Gro IP Inc.) | Canada | IP subsidiary | Deconsolidated |
Roto-Gro Technology Inc. | Canada | Technology subsidiary | Deconsolidated |
Global Fertigation Solutions Inc. (ex-Hanson Fertigation assets) | USA (Nevada) | Fertigation / water treatment | Voluntary administration; dissolved 23 Jun 2020 |
Revenue by Segment
| Segment (geography) | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Australia total revenue (AUD K) | 10.4 | 10.1 | 0.2 |
Canada total revenue (AUD K) | 956.3 | 510.5 | 131.4 |
USA total revenue (AUD K) | 225.5 | 0 | 0 |
Mauritius/BVI total revenue (AUD K) | 0 | 0 | 0 |
Group total revenue (AUD K) | 1,192.2 | 520.7 | 131.6 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment — Canada – RotoGro unit sales
| Segment | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Canada – RotoGro unit sales (AUD K) | 678.6 | 0 | 27.1 |
USA – fertigation sales, discontinued (AUD K) | 225.5 | 0 | 0 |
Total customer sales incl. discontinued (AUD K) | 904.1 | 0 | 27.1 |
Revenue by Segment — Australia
| Segment | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Australia (AUD K) | -1,467.2 | -2,049.1 | -10,793.6 |
Canada (AUD K) | -2,806.5 | -2,473.9 | -1,885.4 |
Mauritius/BVI (AUD K) | -11,339.7 | -85.9 | 6.7 |
USA (AUD K) | -262.7 | 0 | 0 |
Group (AUD K) | -15,876.2 | -4,608.9 | -12,672.3 |
Income Statement and Per-Share Data
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
Sales revenue (AUD K) | 464.1 | 1,139.8 | 678.6 | 0 | 27.1 |
Other income incl. grants (AUD K) | — | — | 288.1 | 520.7 | 104.5 |
Cost of goods sold (AUD K) | — | — | -1,036.7 | -10.7 | -189.2 |
Gross profit (AUD K) | — | — | -358.1 | -10.7 | -162.1 |
EBITDA as reported (AUD K) | -2,728.7 | -5,425.9 | -14,277.6 | -3,356.7 | -12,292.3 |
Depreciation & amortisation (AUD K) | — | — | -1,158.6 | -753.3 | -379.9 |
EBIT computed, continuing (AUD K) | — | — | -15,613.5 | -4,110.0 | -12,672.3 |
Finance costs (AUD K) | — | — | 0 | -498.9 | 0 |
Pre-tax loss, continuing (AUD K) | — | — | -15,613.5 | -4,608.9 | -12,672.3 |
Net loss attributable (AUD K) | -3,191.7 | -6,171.8 | -15,876.2 | -4,608.9 | -12,672.3 |
Basic EPS (A$ cents) | -3.82 | -4.80 | -11.20 | -2.20 | -3.74 |
Diluted EPS (A$ cents) | -3.82 | -4.80 | -11.20 | -2.20 | -3.74 |
Dividends per share (A$ cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | — | 145.6 | -40.5 | -100.0 | — |
Gross margin (%) | — | — | -52.8 | — | -597.7 |
EBITDA margin (%) | -588.0 | -476.0 | -2,104.0 | — | -45,331 |
Operating (EBIT) margin (%) | — | — | -2,300.9 | — | -46,732 |
Net margin (%) | -687.7 | -541.5 | -2,339.5 | — | -46,732 |
Balance Sheet
| Metric | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Total assets (AUD K) | 10,575.1 | 11,596.3 | 155.4 |
Cash & equivalents (AUD K) | 345.5 | 1,638.4 | 116.2 |
Inventories (AUD K) | 624.6 | 895.2 | 0 |
Plant & equipment (AUD K) | 1,033.7 | 1,067.4 | 0 |
Intangibles – IP, patents & trademarks (AUD K) | 8,037.4 | 7,605.3 | 0 |
Goodwill (AUD K) | 0 | 0 | 0 |
Short-term borrowings (AUD K) | 0 | 0 | 0 |
Long-term borrowings (AUD K) | 0 | 0 | 0 |
Lease liabilities current (AUD K) | 143.8 | 151.3 | 0 |
Lease liabilities non-current (AUD K) | 210.9 | 49.6 | 0 |
Net debt incl. leases (AUD K) | 9.2 | -1,437.4 | -116.2 |
Contract liabilities / customer deposits (AUD K) | 520.7 | 524.6 | 0 |
Total liabilities (AUD K) | 1,574.4 | 1,099.0 | 168.6 |
Total equity (AUD K) | 9,000.8 | 10,497.3 | -13.1 |
Working capital (AUD K) | -179.2 | 1,695.7 | -13.1 |
Cash Flow
| Metric | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Receipts from customers (AUD K) | 1,132.4 | 0 | 242.2 |
Operating cash flow (AUD K) | -4,177.2 | -2,874.7 | -2,161.7 |
Capex – plant & equipment (AUD K) | -415.5 | -230.8 | -99.0 |
Free cash flow (AUD K) | -4,592.7 | -3,105.6 | -2,260.7 |
Equity issued, net (AUD K) | 2,119.2 | 3,309.8 | 2,022.3 |
Convertible note proceeds (AUD K) | 0 | 1,250.0 | 0 |
Dividends paid (AUD K) | 0 | 0 | 0 |
Share buybacks (AUD K) | 0 | 0 | 0 |
Cash derecognised on deconsolidation (AUD K) | 0 | 0 | -1,197.0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
ROE (%) | -102.3 | -47.3 | -241.7 |
ROA (%) | — | -41.6 | -215.7 |
Current ratio (x) | 0.87 | 2.62 | 0.92 |
Debt / equity excl. leases (x) | 0 | 0 | 0 |
Lease liabilities / equity (%) | 3.9 | 1.9 | 0 |
Interest coverage, EBIT / finance costs (x) | — | -8.2 | — |
Asset turnover (x) | — | 0 | 0.005 |
Revenue by Region
| Region | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Canada (AUD K) | 678.6 | 0 | 27.1 |
USA (AUD K) | 225.5 | 0 | 0 |
Australia (AUD K) | 0 | 0 | 0 |
Europe (AUD K) | 0 | 0 | 0 |
Geographic Revenue
| Region | FY2021 YoY (%) | FY2022 YoY (%) |
|---|---|---|
Canada | -100 | n/m (from nil) |
USA | -100 (operations dissolved 23 Jun 2020) | — |
Product Lines
| Product line | Canada (AUD K) | USA (AUD K) | Total (AUD K) |
|---|---|---|---|
RotoGro unit sales | 678.6 | 0 | 678.6 |
Fertigation sales (discontinued) | 0 | 225.5 | 225.5 |
Share Price
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
Share price at 30 June (AUD) | 0.35 | 0.36 | 0.16 | 0.05 | 0.04 |
Return metric
| Return metric | Value |
|---|---|
FY2018 → FY2021 (3 years) | −88.9% |
FY2017 → FY2021 (4 years) | −88.6% |
IPO (Feb 2017) → last trade (~Feb 2022) | ≈ −97% (A$0.355 June 2017 trade → ≈A$0.011) |
Pearler 5-year average annual capital growth (aggregator) | −18.0% |
1-, 3- and 5-year returns to Oct 2026 | Not applicable: no quotation since Feb 2022; delisted Mar 2024 |
Share Count (millions) and Capital Markets Data
| Metric | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Ordinary shares on issue at 30 June (millions) | 149.0 | 279.7 | 342.6 |
Issued capital (AUD K) | 28,808.0 | 34,400.7 | 36,240.9 |
Share Price & Returns
| Date | Instrument | Amount (AUD) | Price (AUD) |
|---|---|---|---|
Feb 2017 | IPO (Barclay Wells) | 3.6M | — |
2018 (n/d) | Placement | 4.56M | — |
31 Dec 2019 | Placement (with A$0.20 options) | — | — |
Aug–Oct 2020 | Obsidian convertible notes | 1.25M | Conversions at ≈A$0.039–0.044 |
30 Nov 2020 | Placement (Peak) | 1.53M | 0.04 |
2 Mar 2021 | Placement | 2.00M | 0.05 |
23 Jul 2021 | Placement (EverBlu) | 2.20M | 0.035 |
26 Sep 2022 | Placement | 0.05M | 0.001 |
Attribute Details
| Attribute | Status |
|---|---|
Dividends | None ever paid, recommended or declared |
Buyback authorisations | None ("no current on-market share buy-back", FY2022 Note 22) |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt maturity profile | No debt. Lease liabilities were nil after deconsolidation |
Analyst consensus | None. Coverage limited to paid or sponsored content (Stockhead advertiser disclosures; Kalkine) |
Analyst Conclusions
Management guidance
None. The last forward-looking statement was in the FY2022 going-concern note (31 Aug 2023): the directors believed the entity could raise capital and acquire new assets. No such transaction followed. There is no consensus.
Bull-case arguments (residual and theoretical)
-
Clean, debt-free shell. The entity carried no borrowings and only A$169k of liabilities (FY2022). A promoter could theoretically revive it via creditor settlement and recapitalisation before strike-off is completed.
-
Validated IP may retain value elsewhere. A court-confirmed Canadian patent and a granted Australian patent could be monetised by whoever now controls them, though this value likely accrues to the bankruptcy estate rather than RGI shareholders.
-
Accumulated tax losses. About A$37.3M of accumulated losses could theoretically be valuable. Use is heavily constrained by continuity-of-ownership and same-business tests, and value would require the entity to survive.
Bear-case arguments (dominant)
-
No operating assets, no listing, no cash flow. All subsidiaries were deconsolidated, all intangibles impaired to nil, and the ASX listing removed on 1 Mar 2024.
-
Deregistration in progress. ASIC strike-off action was initiated on 6 Aug 2026. Completion would dissolve the company and extinguish shares.
-
Track record of non-conversion. Over five years, headline agreements totalling more than A$12M (Verity A$10M; Canniberia A$2.03M) produced no recognised revenue. Cumulative reported losses of ≈A$43.5M were funded by dilutive equity. The audit disclaimer means even the final accounts cannot be relied upon.
Catalysts and monitorables (next 12 months)
-
ASIC deregistration notice publication, or any objection or reinstatement application.
-
Any lodgement of outstanding financial reports (FY2023 onward), or any notice of a creditors' scheme or recapitalisation proposal.
-
Disposition of RotoGro patents by the Canadian bankruptcy trustee.
-
Any shareholder communication via the registry (Computershare) regarding residual value.
Concluding analyst verdict
Roto-Gro International Limited is a case study in why a credible patent is not enough for a hardware-led agtech business. Product-market fit, unit economics and patient capital also matter. The company's core idea, a stackable rotating hydroponic garden that multiplies canopy per square metre, was genuine and defensible. RotoGro won a Federal Court-confirmed outcome over the Canadian patent and secured an Australian grant. But from its A$3.6M IPO in February 2017 to the bankruptcy of its Canadian operating subsidiary on 31 May 2022, the business never generated more than A$1.14M of annual sales. In its last full year of trading at scale (FY2020) it sold units at a negative gross margin.
Strategy oscillated: equipment vendor, then aspiring cannabis cultivator (Supra THC, Gibio, 420 Inc.), then asset-light licensor (Verity Greens). Each pivot was funded by small, heavily optioned placements and a toxic-style convertible note. Each headline agreement was conditional on counterparties who themselves lacked funding. The vertical-farming capital drought from 2022 and Canadian cannabis oversupply removed any remaining path.
The governance signals deteriorated in step. Directors waived fees. The CEO received 27 million options weeks before the collapse. Shareholders delivered a remuneration first strike. The final accounts were lodged 14 months late with an audit disclaimer, showing negative net assets of A$13,128. The ASX removed the company on 1 March 2024, and ASIC initiated strike-off action on 6 August 2026.
Verdict: The equity should be regarded as having no realistic recoverable value. For investors, the residual relevance is limited to tax-loss documentation and monitoring the deregistration process. For industry observers, the useful lesson is the reminder that patent quality, headline contract values and yield-per-square-metre claims are weak predictors of commercial success in controlled-environment agriculture. Rating: Not investable / defunct entity.
End of dossier. Figures are drawn from the company's ASX-lodged Appendix 4E / annual reports for FY2021 (31 Aug 2021) and FY2022 (31 Aug 2023), the December 2020 quarterly report, and ASX notices (22 Jan 2024; 1 Mar 2024), supplemented by Valens GroWorks/CNW, Stockhead, Business News (WA), Business News Australia, Kalkine, MarketScreener, MarketBeat, Market Index, Wisesheets and delisted.com.au. Items marked n/d or left blank were not publicly disclosed in the sources reviewed. The FY2022 financial statements are subject to an auditor's disclaimer of opinion.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Background / education | Other listed directorships | Interest in shares |
|---|---|---|---|---|---|
Michael Carli | Non-Executive Chairman (formerly Managing Director) | Since inception (2015) | Toronto-area corporate, commercial and IP lawyer for 30+ years. BA (York University); JD (University of Western Ontario). Vice-Chair, Easter Seals Ontario; former Chairman, Villanova College; member of the Law Society of Ontario and the Intellectual Property Institute of Canada. Director and President of all Canadian subsidiaries | — | 164,994 (post-consolidation) |
Terry Gardiner | Non-Executive Director | Since IPO era (about 2017) | 20+ years in capital markets, stockbroking and derivatives. Director, Barclay Wells Ltd (IPO manager) | Cazaly Resources (CAZ), Galan Lithium (GLN), Charger Metals (CHR, Chair) | 4,903 (post-consolidation) |
Peter Hatfull | Executive Director (appointed NED 19 Apr 2022); Company Secretary (from 5 May 2022) | 2022– | 40+ years in board and executive roles; business optimisation, capital raising, restructuring | Melodial Global Health (ME1). Former: Pivotal Metals (PVT, resigned Aug 2023), Roots Sustainable Agricultural Technologies (ROO, resigned Aug 2022), eSense Labs (ESE, delisted Sep 2021) | Nil |
Company Secretary (unnamed in reviewed sources), age 56 | Corporate Secretary | Appointed ~18–19 Jan 2024 | — | — | — |
Executive Leadership Team
| Name | Role | Dates | Notes |
|---|---|---|---|
Michael Di Tommaso | Executive Director; CEO from 25 Jan 2021 | Joined 2018 as Operations Manager – Cultivation; later COO; resigned 8 Aug 2022 | BA Criminal Justice; JD (University of Ottawa). Base salary CAD 216,000. Granted 27M options (Dec 2021) |
Adam Clode | CEO | 1 Jul 2019 – 25 Jan 2021 | Base CAD 216,000. Settled in 12,265,622 shares (31 May 2021); 8M performance rights lapsed or forfeited |
Matthew O'Kane | NED | 30 Nov 2020 – 19 Oct 2021 | BEcFin, MBA (RMIT) |
Leighton Richards | NED | 19 Oct 2021 – 1 Mar 2022 | MBA, MMktg (Monash) |
Jamie Myers | NED | – 30 Nov 2020 | Associate Director, Baker Young Stockbrokers |
Michael Slater | Director | – 28 Feb 2020 | — |
Melanie Leydin | Company Secretary & CFO | – 30 Apr 2021 | — |
Karla Mallon | CFO | 30 Apr 2021 – (n/d) | Chartered Accountant (Automic Group) |
Andrew Palfreyman | Company Secretary | 30 Apr 2021 – 5 May 2022 | Corporate lawyer |
Directors' Remuneration
| Name | Year | Cash salary/fees | Superannuation | Equity-settled | Total |
|---|---|---|---|---|---|
Michael Di Tommaso | FY2022 | 0 | 0 | 135,500 | 135,500 |
Terry Gardiner | FY2022 | 24,000 | 2,400 | 0 | 26,400 |
Leighton Richards | FY2022 | 17,621 | 1,825 | 2,900 | 22,346 |
Matthew O'Kane | FY2022 | 14,323 | 1,432 | 0 | 15,755 |
Michael Carli | FY2022 | 0 | 0 | 0 | 0 (fees waived) |
Peter Hatfull | FY2022 | 0 | 0 | 0 | 0 (fees waived) |
Total KMP | FY2022 | 55,944 | 5,657 | 138,400 | 200,001 |
Adam Clode | FY2021 | 0 | 0 | 542,866 | 542,866 |
Michael Di Tommaso | FY2021 | 199,653 | 0 | 0 | 199,653 |
Michael Carli | FY2021 | 43,876 | 0 | 29,555 | 73,431 |
Terry Gardiner | FY2021 | 48,000 | 4,560 | 0 | 52,560 |
Total KMP | FY2021 | 319,529 | 7,220 | 592,421 | 919,170 |
Total KMP | FY2020 | 554,591 | 19,375 | 464,349 | 1,038,315 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Relative positioning vs RotoGro |
|---|---|---|---|
Rotary/orbital gardens | Omega Garden / Volksgarden (Canada) | Private | Closest technology analogue (rotary hydroponic carousels); longer commercial history |
Rotary/orbital gardens | RavenQuest BioMed (Canada) | Formerly CSE-listed | Built "orbital gardens"; settled patent infringement in RotoGro's favour (FY2021) |
Indoor vertical farming (operators/tech) | AeroFarms (USA) | Private | Large-scale aeroponic operator; public reports indicate a Chapter 11 filing in 2023 |
Indoor vertical farming | AppHarvest (USA) | Formerly NASDAQ | High-tech greenhouses; public reports indicate a Chapter 11 filing in 2023 |
Indoor vertical farming | Bowery Farming (USA) | Private | Public reports indicate it ceased operations in late 2024 |
Indoor vertical farming | Plenty Unlimited (USA) | Private | Public reports indicate a Chapter 11 filing in 2025 |
Indoor vertical farming | Infarm (Germany) | Private | Modular in-store farms; publicly reported retrenchment from 2022 |
Indoor farming tech | Affinor Growers (Canada, CSE) | Listed micro-cap | Vertical tower growing technology; similar micro-cap profile |
Agtech micro-caps (ASX) | Roots Sustainable Agricultural Technologies (ASX: ROO) | Listed micro-cap | Root-zone temperature technology; shared director (Hatfull) |
Cannabis cultivation equipment & supply | Hydrofarm Holdings (NASDAQ: HYFM) | Listed | Scale hydroponics equipment distributor/manufacturer |
Cannabis cultivation equipment & supply | GrowGeneration (NASDAQ: GRWG) | Listed | Hydroponic retail/distribution |
Cannabis cultivation equipment & supply | Hawthorne Gardening (Scotts Miracle-Gro) | Division of NYSE: SMG | Dominant branded hydroponic supplier |
Fertigation / nutrients | Netafim (Orbia), Priva, Argus Controls | Corporate | Established fertigation and climate-control vendors versus the sub-scale Hanson line |
Competitor Detail
| Metric | RotoGro (FY2021) |
|---|---|
Revenue | A$0 (sales); A$1.14M peak (FY2019) |
Growth | −100% (FY2021) |
Gross margin | n/m (−52.8% FY2020) |
R&D intensity |
|
Recent Developments
Note on coverage: * The strict 18-month window (April 2025 – October 2026) contains only one verifiable event, because the company has been dormant and delisted since March 2024. To give a usable register, the table extends back to the start of the company's terminal phase (July 2021). Entries are in chronological order.



